Drug Screening Market Share

Statistics for the 2023 & 2024 Drug Screening market share, created by Mordor Intelligence™ Industry Reports. Drug Screening share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

INSTANT ACCESS

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Drug Screening Industry

The drug screening market is semi-consolidated in nature due to the presence of several companies operating globally and regionally. The companies are involved in various strategic activities such as product launches, collaborations, and acquisitions. Key players operating in the global drug screening market are LabCorp (Laboratory Corporation of America Holdings), Quest Diagnostics, Abbott Laboratories, Thermo Fisher Scientific Inc., Alfa Scientific Designs Inc., OraSure Technologies Inc., Siemens Healthineers, F. Hoffmann-La Roche Ltd, Shimadzu Corporation, LifeLock Technologies, Drägerwerk AG & Co. KGaA, and Premier Biotech Inc.

Drug Screening Market Leaders

  1. Quest Diagnostics

  2. Abbott Laboratories

  3. Thermo Fisher Scientific, Inc.

  4. Siemens Healthineers

  5. LabCorp (Laboratory Corporation of America Holdings)

*Disclaimer: Major Players sorted in no particular order

Drug Screening Market Concentration

Drug Screening Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)